AtriCure, Inc. — Director's Dealing 2021

May 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2021-05-07

Reporting Person: Drake Scott William (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-07	Common Stock	M	38641	$8.98	Acquired	79677	Direct
2021-05-07	Common Stock	S	38641	$77.90	Disposed	41036	Direct
2021-05-10	Common Stock	M	4631	$8.98	Acquired	45667	Direct
2021-05-10	Common Stock	S	4631	$76.52	Disposed	41036	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-07	Stock Option (Right to Buy)	$8.98	M	38641	Disposed	2023-09-03	Common Stock (38641)	Direct
2021-05-10	Stock Option (Right to Buy)	$8.98	M	4631	Disposed	2023-09-03	Common Stock (4631)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $77.52 to $79.13 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This transaction was executed in multiple trades at prices ranging from $76.00 to $76.84 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: These options were granted on September 3, 2013. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.